
This study examines the prevalence of growth retardation, hypothyroidism, and diabetes mellitus in children and adolescents with β-thalassemia major (BTM) treated at Dubai Thalassemia Centre. The study analyzed data from 105 participants; it was found that a significant proportion experienced reduced height velocity, particularly among females. While diabetes mellitus was absent, pre-diabetes was detected in some. Additionally, elevated TSH levels were observed in a subset. Growth delay emerged as a primary concern. Effective treatment, including transfusion and chelation, appears to mitigate endocrinopathies in this cohort.
Like
Save
Share